Tycoon Group Holdings Limited (3390) AI Stock Analysis

• Market Cap: HK$330.78M
• Dividend Yield: 18.92%
• Average Volume (3M): 2.28M
• Price to Earnings (P/E): 88.1
• Beta (1Y): -0.17
• Revenue Growth: -26.91%
• EPS Growth: -98.72%
• Country: HK
• Employees: 258
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Pharmaceuticals
• EPS (TTM): -0.02
• Shares Outstanding: 894,000,000
• 10 Day Avg. Volume: 3,052,400
• 30 Day Avg. Volume: 2,276,800
• PEG Ratio: -0.89
• Price to Book (P/B): 0.59
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -18.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$0.50
• Price Target Upside: 35.14% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 45 Neutral
• Price Target: HK$0.50 ▲(35.14%Upside)

The stock's overall score is primarily impacted by weak technical analysis and financial performance. The company faces significant challenges with cash flow and income stability. High leverage and declining profitability further contribute to the risk profile. While the high dividend yield offers potential appeal, it is overshadowed by concerns about financial health and stock price momentum.

Tycoon Group Holdings Limited Business Overview & Revenue Model

Company Description

Tycoon Group Holdings Limited (3390) is a Hong Kong-based investment holding company primarily engaged in the distribution and retail of healthcare and personal care products. The company operates through various segments, including proprietary Chinese medicine, health supplements, and personal care products. Tycoon Group Holdings Limited leverages both online and offline channels to distribute its products, aiming to meet the diverse health and wellness needs of its customers.

How the Company Makes Money

Tycoon Group Holdings Limited generates revenue through its diverse portfolio of healthcare and personal care products, which are distributed via multiple channels including retail chains, e-commerce platforms, and direct sales. The company capitalizes on its strong distribution network and strategic partnerships with major healthcare brands to ensure a broad market reach. Revenue streams include sales from proprietary Chinese medicines, health supplements, and a variety of personal care items. Additionally, the company benefits from economies of scale and extensive market knowledge, which help optimize its supply chain and enhance profitability.

Tycoon Group Holdings Limited Financial Statement Overview

Summary

Tycoon Group Holdings Limited exhibits a mixed financial profile with moderate weaknesses in income and cash flow statements. Though there are some strengths in the balance sheet, notably asset growth, the volatility in income and cash flow raises concerns about the company's financial health and operational efficiency.

Income Statement

The income statement shows fluctuating performance over the past years. The gross profit margin has been relatively stable, but recent declines in revenue growth and net profit margins are concerns. The company has struggled to maintain consistent profitability, with recent net income levels significantly lower compared to past years. This volatility indicates potential challenges in revenue and cost management.

Balance Sheet

The balance sheet reflects moderate stability with a relatively balanced debt-to-equity ratio, but there is a noticeable increase in total debt over the years, raising leverage concerns. Stockholders' equity has been increasing, which is a positive sign, but the equity ratio has been inconsistent. The company's assets have grown, but liabilities have increased at a faster rate, which could pose risks if not managed properly.

Cash Flow

Cash flow analysis indicates significant challenges, particularly with operating cash flow being negative in several years. Free cash flow has also been erratic, with recent negative figures suggesting cash management issues. The operating cash flow to net income ratio indicates inefficiencies in converting income into cash. The company needs to focus on improving cash flow stability to mitigate financial stress.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	876.04M	1.20B	1.19B	888.87M	505.99M
Gross Profit	232.66M	321.10M	243.53M	135.01M	71.06M
EBITDA	35.85M	356.41M	85.26M	5.45M	-49.05M
Net Income	3.24M	297.32M	43.75M	-18.82M	-61.13M
Balance Sheet
Total Assets	1.01B	988.95M	1.01B	881.46M	619.91M
Cash, Cash Equivalents and Short-Term Investments	34.02M	39.10M	74.60M	71.63M	119.34M
Total Debt	330.98M	206.16M	341.60M	239.08M	198.32M
Total Liabilities	516.61M	445.40M	718.96M	620.20M	329.47M
Stockholders Equity	478.85M	536.23M	293.64M	257.92M	288.16M
Cash Flow
Free Cash Flow	-78.94M	7.97M	-64.48M	-50.11M	-119.41M
Operating Cash Flow	-76.62M	11.86M	-63.03M	-42.20M	-107.97M
Investing Cash Flow	48.55M	45.70M	-16.61M	-26.25M	-74.95M
Financing Cash Flow	25.62M	-92.36M	86.11M	20.35M	251.96M

Tycoon Group Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.37
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3390, the sentiment is Neutral. The current price of 0.37 is above the 20-day moving average (MA) of 0.36, below the 50-day MA of 0.39, and below the 200-day MA of 2.49, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 42.64 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:3390.

Tycoon Group Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1110	71 Outperform	HK$357.83M	7.54	6.61%	9.43%	-3.59%	4.81%
1612	68 Neutral	HK$431.20M	6.14	12.35%	5.00%	11.56%	21.20%
1643	61 Neutral	HK$410.40M	32.57	2.03%	―	-39.05%	-80.60%
Sector *	60 Neutral	HK$17.07B	6.10	-7.44%	2.88%	11.55%	-28.15%
1518	59 Neutral	HK$410.00M	7.90	8.82%	2.19%	-10.82%	-44.11%
2393	51 Neutral	HK$319.16M	0.32	1417.08%	―	-20.01%	―
3390	45 Neutral	HK$330.78M	88.10	0.64%	18.92%	-26.91%	-98.72%

Tycoon Group Holdings Limited Corporate Events

Tycoon Group Holdings Limited Updates Nomination Committee Terms

Tycoon Group Holdings Limited has announced amendments to the terms of reference for its Nomination Committee, effective from July 1, 2025. These changes emphasize diversity and independence within the committee, requiring a minimum of three members, the majority being independent non-executive directors, and at least one member of a different gender. This move is likely to enhance the company’s governance practices and strengthen its commitment to diversity and independent oversight, potentially impacting its reputation positively among stakeholders.

Tycoon Group Holdings Limited Announces Board Restructuring

Tycoon Group Holdings Limited has announced changes to its board of directors, effective from July 1, 2025. The company, which is incorporated in the Cayman Islands, has appointed Mr. Wong Ka Chun Michael as the Chairman and Chief Executive Officer. The board will also include a mix of non-executive and independent non-executive directors, each serving on various committees such as Audit, Remuneration, Nomination, and Corporate Governance. This restructuring is likely to impact the company’s governance and strategic direction, potentially influencing its market positioning and stakeholder relations.

Tycoon Group Announces Board Changes with New Appointments

Tycoon Group Holdings Limited has announced changes in its board of directors, with the resignation of Mr. Hu Yang as a non-executive director due to work adjustments, effective July 1, 2025. The company has appointed Mr. Ng Kwan Ho and Mr. Cao Ran as non-executive directors, also effective from July 1, 2025. Mr. Ng brings extensive experience in marketing and brand management, having held senior positions in various companies, including JBM (Healthcare) Limited and Amway Hong Kong Limited. These changes are expected to bring new perspectives and expertise to the company’s board, potentially impacting its strategic direction and market positioning.

Tycoon Group Secures Unanimous Approval at AGM

Tycoon Group Holdings Limited announced that all resolutions proposed at its Annual General Meeting on 30 May 2025 were approved by shareholders. The resolutions included the re-election of directors, adoption of new articles of association, and granting of mandates for share repurchase and issuance. This unanimous approval reflects strong shareholder support and positions the company for strategic flexibility in its operations.

Tycoon Group Sets Fixed Term for Distribution Agreements with Europharm and Jacobson Medical

Tycoon Group Holdings Limited has entered into supplemental agreements with Europharm and Jacobson Medical to establish a fixed period ending on 31 March 2028 for their distribution agreements. The proposed annual caps for the purchase of products under these agreements have been set, and the transactions are subject to annual review and disclosure requirements under the Listing Rules, but are exempt from certain approval requirements.

Tycoon Group Completes Share Issuance and Establishes New Shareholder Connections

Tycoon Group Holdings Limited has completed the issuance of 94,000,000 shares under a general mandate at an issue price of HK$0.5 per share, with the completion taking place on May 22, 2025. This transaction has resulted in the Subscriber, an indirect wholly-owned subsidiary of Jacobson Pharma, becoming a substantial shareholder with a 16.84% stake in the company, thus establishing new connected person relationships and ongoing connected transactions under the Listing Rules.

Tycoon Group Announces Share Issue to Boost Financial Stability

Tycoon Group Holdings Limited announced a proposed issue of shares under a general mandate, aiming to raise approximately HK$46.7 million. The proceeds are intended for general working capital, including inventory purchases, logistics, marketing, and other operational needs. The subscription price is set at a premium, reflecting confidence in the company despite recent financial challenges. This move is expected to strengthen the company’s financial position, reduce debt-to-equity ratio, and enhance stakeholder confidence, especially following a recent forced-sale event.

Tycoon Group Expands Southeast Asian Market and E-commerce Operations

Tycoon Group Holdings Limited has announced supplemental information regarding its continuing connected transactions, focusing on the 2025 Master Sale and Purchase Agreement with Talent Smart Group. The company anticipates increased purchases of Talent Smart Products due to the launch of 24 new products and the expansion of its distribution channels in Southeast Asia and e-commerce platforms in the PRC. The reinstatement of Combo Win Asia Limited as a wholly-owned subsidiary is expected to enhance the company’s e-commerce capabilities, potentially boosting sales and market reach.

Tycoon Group Holdings Limited Announces Share Subscription to Fuel Growth

Tycoon Group Holdings Limited has entered into a Subscription Agreement to issue 94,000,000 shares at HK$0.5 each, representing approximately 11.75% of its current issued share capital. The proceeds, estimated at HK$46.7 million after expenses, will be used to invest in core business growth and improve supply chain and logistics operations, positioning the company for expansion.